AI-designed universal vaccine
Coverage of AI-designed universal vaccine in the Nexus archive.
- AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics
An AI-designed 'universal vaccine' targeting multiple coronaviruses has passed its first human clinical trial, showing safety and triggering an immune response in 39 volunteers. Developed by researchers from the Universities of Cambridge and Southampton, the vaccine uses a computer-simulated 'super-antigen' to combat evolving viruses, including those not yet discovered. The needle-free micro-fluid jet delivery method aims to simplify mass administration.
- First AI-designed ‘universal vaccine’ tested in humans
A first-in-human trial tested an AI-designed 'universal vaccine' targeting multiple viruses, showing a 'modest' immune response. The vaccine's active ingredient was entirely created by artificial intelligence, marking a milestone in vaccine development.